Author:
Wagner Jairo,de Carvalho Campos Neto Guilherme,Oliveira Júlio Cesar Silveira,Fonseca Ricardo Cavalcante Quartim
Publisher
Springer International Publishing
Reference5 articles.
1. Christopher C, Riedl CC, Slobod E, Jochelson M, Morrow M, et al. Retrospective analysis of 18F-FDG PET/CT for staging asymptomatic breast cancer patients younger than 40 years. J Nucl Med. 2014;55:1578–83. Retrospective analysis showing PET-CT impact in asymptomatic patients with breast tumors
2. Duarte C, Bastidas F, De Los Reyes A, Martínez MC, Hurtado G, Gómez MC, et al. Randomized controlled clinical trial comparing radioguided occult lesion localization with wire-guided lesion localization to assess their efficacy and accuracy in the localization of nonpalpable breast lesions. Surg (United States). 2016;159(4):1140–5. The study demonstrates similar effectiveness between the ROLL technique and the wire-guided lesion localization of non-palpable breast lesions
3. Groheux D, Giacchetti S, Rubello D, et al. The evolving role of PET/CT in breast cancer. Nucl Med Commun. 2010;31(4):271–3. General review on the use of PET-CT in breast tumors
4. Lyman GH, Somerfield MR, Bosserman LD, Perkins CL, Weaver DL, Giuliano AE. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2017;35(5):561–4. Recommendations of the American Society of Clinical Oncology for conducting sentinel lymph node biopsy
5. Tabouret-Viaud C, Botsikas D, Delattre B, et al. PET/MR in breast cancer. Semin Nucl Med. 2015;45:304–21. Review on the current use of PET-MR in breast tumors and perspectives